some tumors rely on it for survival under high oxidative pressure, while deficiencies in healthy cells might promote tumor initiation through DNA damage
For excluded molecules, a route-triage strategy directs candidates toward pulmonary, nasal, buccal, or long-acting injectable delivery
We cannot discuss GLP-1 receptor agonists without discussing weight loss, because that is the context in which most of your patients, and frankly most of the popular press, know these medications
The most commonly reported are mild fatigue or lightheadedness shortly after injection, which typically resolve quickly
Studies show positive responses when added to existing regimens, but no definitive link between drug exposure and desirable clinical outcomes